product summary
Loading...
company name :
Tocris Bioscience
product type :
chemical
product name :
(Z)-4-Hydroxytamoxifen
catalog :
3412/10
quantity :
10 mg (also 50 mg)
price :
238 USD
more info or order :
citations: 5
Reference |
---|
product information
brand :
Tocris, a Bio-Techne Brand
catalog number base :
3412
SKU :
3412/10
product name :
(Z)-4-Hydroxytamoxifen
Description :
Metabolite of tamoxifen (Cat. No. 0999)
target :
Estrogen and Related Receptor Modulators
category :
Small Molecules
unit size :
10 mg (also 50 mg)
purity :
98%
observed molecular weight :
387.51
url print :
?utm_source=labome&utm_medium=referral&utm_campaign=product&utm_term=smallmolecules
details of functionality :
( Z )-4-Hydroxytamoxifen is an estrogen receptor antagonist (IC50 = 27 M). ( Z )-4-Hydroxytamoxifen is a Tamoxifen (Cat. No. 0999) metabolite; that exhibits greater potency than the parent compound. ( Z )-4-Hydroxytamoxifen also activates intein-linked inactive Cas9, reducing off-target CRISPR-mediated gene editing; system has ~25-fold higher specificity than wtCas9. ( Z )-4-Hydroxytamoxifen binds to voltage-gated sodium channels, near the intracellular gate and inhibits the sodium current by delaying channel recovery from the inactivated state (IC50 values are 297 nM and 2.1 ?M for NavM and human Nav, respectively in HEK cells); this inhibition is independent of estrogen receptor modulation. Chemotherapeutic agent.
extended description :
Metabolite of tamoxifen (Cat. No. 0999)
chemical name text :
4-[(1Z)-1-[4-[2-(Dimethylamino)ethoxy]phenyl]-2-phenyl-1-buten-1-yl]phenol
formula :
C 26 H 29 NO 2
formula text :
C26H29NO2
cas num :
68047-06-3
USD :
238 USD
product details :
Metabolite of tamoxifen (Cat. No. 0999)
alt names :
4-OH-TAM
storage :
Store at +4°C
more info or order :
company information

Tocris Bioscience
The Watkins Building
Atlantic Road
Avonmouth, Bristol
BS11 9QD
Atlantic Road
Avonmouth, Bristol
BS11 9QD
info@bio-techne.com
https://www.tocris.com800-343-7475
headquarters: UK
browse more products
questions and comments